Chargement en cours...
Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
The WHO biowaiver procedure for BCS Class II weak acids was evaluated by running two multisource IR ibuprofen drug products (Ibuprofen, 200 mg tablets, Tatchempharmpreparaty, Russia and Ibuprofen, 200 mg tablets, Biosintez, Russia) with current Marketing Authorizations (i.e. in vivo bioequivalent) t...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3374563/ https://ncbi.nlm.nih.gov/pubmed/22707831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0250-474X.95643 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|